Skip to main content
PMC home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 2001;112:224–234.

Patients, populations and policy: patient outcomes in chronic kidney disease.

N R Powe 1
PMCID: PMC2194417  PMID: 11419454

Abstract

Chronic kidney disease represents an interesting illustration for evaluating an epidemic of chronic illness, the impact of care processes and technology on health outcomes, the impact of financial incentives and cost containment on health outcomes, and the choices society must consider in responding to a chronic illness. The evidence suggests that strong economic pressures exist in the care of chronic kidney disease and that cost containment is important. The results in large part reflect the impact of economic pressures on clinical decision making in the absence of good evidence on outcomes. To improve clinical decision making we need valid evidence linking specific processes of care to patient outcomes. Specific processes amenable to study include the provision of preventive services, physician and nurse technical and interpersonal care and adherence to clinical practice guidelines. The ESRD Quality Study (EQUAL) currently underway and supported by the National Institutes of Diabetes and Digestive and Kidney Diseases, may help to guide physicians and centers in caring for their patients with chronic kidney disease. This investigation examines the relation between process of care and outcomes and expands outcomes measure to include disease-specific quality-of-life measures and patient satisfaction and accounts for case mix using the Index of Co-Existent Disease, a measure of the extent of different comorbid diseases as well as their severity (18,19,20). Better data on how processes of care are linked to health outcomes can inform decision making and allow educated cost cutting and quality maintenance.

Full text

PDF
228

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agodoa L. Y., Wolfe R. A., Port F. K. Reuse of dialyzers and clinical outcomes: fact or fiction. Am J Kidney Dis. 1998 Dec;32(6 Suppl 4):S88–S92. doi: 10.1016/s0272-6386(98)70169-6. [DOI] [PubMed] [Google Scholar]
  2. Athienites N. V., Miskulin D. C., Fernandez G., Bunnapradist S., Simon G., Landa M., Schmid C. H., Greenfield S., Levey A. S., Meyer K. B. Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial. 2000 Sep-Oct;13(5):320–326. doi: 10.1046/j.1525-139x.2000.00095.x. [DOI] [PubMed] [Google Scholar]
  3. Brancati F. L., Whittle J. C., Whelton P. K., Seidler A. J., Klag M. J. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 1992 Dec 2;268(21):3079–3084. [PubMed] [Google Scholar]
  4. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988 Sep 23;260(12):1743–1748. doi: 10.1001/jama.260.12.1743. [DOI] [PubMed] [Google Scholar]
  5. Evans R. W., Blagg C. R., Bryan F. A., Jr Implications for health care policy. A social and demographic profile of hemodialysis patients in the United States. JAMA. 1981 Feb 6;245(5):487–491. doi: 10.1001/jama.245.5.487. [DOI] [PubMed] [Google Scholar]
  6. Furth S. L., Hwang W., Neu A. M., Fivush B. A., Powe N. R. For-profit versus not-for-profit dialysis care for children with end stage renal disease. Pediatrics. 1999 Sep;104(3 Pt 1):519–524. doi: 10.1542/peds.104.3.519. [DOI] [PubMed] [Google Scholar]
  7. Garg P. P., Frick K. D., Diener-West M., Powe N. R. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med. 1999 Nov 25;341(22):1653–1660. doi: 10.1056/NEJM199911253412205. [DOI] [PubMed] [Google Scholar]
  8. Griffiths R. I., Powe N. R., Gaskin D. J., Anderson G. F., de Lissovoy G. V., Whelton P. K. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. Health Serv Res. 1994 Oct;29(4):473–487. [PMC free article] [PubMed] [Google Scholar]
  9. Klag M. J., Whelton P. K., Randall B. L., Neaton J. D., Brancati F. L., Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997 Apr 23;277(16):1293–1298. [PubMed] [Google Scholar]
  10. Krop J. S., Coresh J., Chambless L. E., Shahar E., Watson R. L., Szklo M., Brancati F. L. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med. 1999 Aug 9;159(15):1777–1783. doi: 10.1001/archinte.159.15.1777. [DOI] [PubMed] [Google Scholar]
  11. Powe N. R., Griffiths R. I., Anderson G. F., de Lissovoy G., Watson A. J., Greer J. W., Herbert R. J., Whelton P. K. Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients. Am J Kidney Dis. 1993 Oct;22(4):557–567. doi: 10.1016/s0272-6386(12)80929-2. [DOI] [PubMed] [Google Scholar]
  12. Powe N. R., Griffiths R. I., Bass E. B. Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease. J Am Soc Nephrol. 1993 Apr;3(10):1660–1671. doi: 10.1681/ASN.V3101660. [DOI] [PubMed] [Google Scholar]
  13. Powe N. R., Griffiths R. I., Greer J. W., Watson A. J., Anderson G. F., de Lissovoy G., Herbert R. J., Eggers P. W., Milam R. A., Whelton P. K. Early dosing practices and effectiveness of recombinant human erythropoietin. Kidney Int. 1993 May;43(5):1125–1133. doi: 10.1038/ki.1993.158. [DOI] [PubMed] [Google Scholar]
  14. Powe N. R., Griffiths R. I., de Lissovoy G., Anderson G. F., Watson A. J., Greer J. W., Herbert R. J., Eggers P. W., Milam R. A., Whelton P. K. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval. JAMA. 1992 Sep 16;268(11):1434–1440. [PubMed] [Google Scholar]
  15. Powe N. R. Prescription drugs in Medicare and the ESRD program. Semin Nephrol. 2000 Nov;20(6):535–542. [PubMed] [Google Scholar]
  16. Rubin H. R., Jenckes M., Fink N. E., Meyer K., Wu A. W., Bass E. B., Levin N., Powe N. R. Patient's view of dialysis care: development of a taxonomy and rating of importance of different aspects of care. CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. Am J Kidney Dis. 1997 Dec;30(6):793–801. doi: 10.1016/s0272-6386(97)90084-6. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES